| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |